Loading stock data…
Globus Medical, Inc. (GMED)
$76.49+1.07 (+1.42%)
Market ClosedLast close Jul 24
Globus Medical, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Globus Medical, Inc. in the Healthcare sector is trading at $76.49 with a market capitalization of $10.6B. Wall Street consensus targets $105.75 (12 analysts), implying a +38.3% move over the next 12 months. The stock is currently 25% below its 52-week high of $101.40, remaining 8.3% below its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the safe zone. Risk note: MACD remains below its signal line. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +38.3% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $759.85M↓ | $826.42M↑ | $769.05M↑ | $745.34M↑ | $598.12M |
| Gross Profit | $525.79M↓ | $565.31M↑ | $516.51M↑ | $496.58M↑ | $402.72M |
| Operating Income | $161.98M↓ | $181.31M↑ | $135.01M↑ | $122.81M↑ | $98.06M |
| Net Income | $124.30M↓ | $140.59M↑ | $118.97M↓ | $202.85M↑ | $75.46M |
Peer Comparison
JNJUNHPFE
Fundamentals
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle scre...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$10.58B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
18.21
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.00
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
12.40%
Volume
Today's trading volume
1.71M
Recent News
Intuitive Surgical Stock Is On Sale, But Is The Growth Story Changing?
The robotic surgery leader's shares have pulled back, forcing investors to weigh a solid recovery record against new questions in its most important market.
Reasons to Retain Globus Medical Stock in Your Portfolio for Now
GMED is gaining share in musculoskeletal solutions with strong implant and trauma growth, backed by a debt-free balance sheet despite cost and FX pressures.
ISRG Stock: The Math Hidden In Its Price
At $353, Intuitive Surgical (ISRG) is being priced to deliver 14.1% revenue growth annually for the next 4 years simply to defend today's 42.1x multiple. That sits below the 21% the business is currently growing at, which is the unusual part. The multiple has already priced in a slowdown that has not yet appeared.
The Robot Maker's Paradox
You can be forgiven for doing a double-take on Intuitive Surgical (ISRG) on Friday. The company posted second-quarter revenue of $2.89 billion, up 19% from a year ago and comfortably ahead of Wall Street estimates. Yet the stock ended the day down 14.1%, closing at a new 52-week low.
What's More Important For Intuitive Surgical: Today's Robots Or Tomorrow's Growth?
The surgical robotics giant beat estimates, but a moderation in its core US market has investors questioning the whole story.